9 Meters Biopharma Inc
Change company Symbol lookup
Select an option...
NMTR 9 Meters Biopharma Inc
LYLT Loyalty Ventures Inc
BOXD Boxed Inc
ALLR Allarity Therapeutics Inc
SIVB SVB Financial Group
NMRD Nemaura Medical Inc
LOGI Logitech International SA
BIOC Biocept Inc
KT KT Corp
SVRA Savara Inc
Go

Health Care : Pharmaceuticals | Small Cap Blend
Company profile

9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for people with rare digestive diseases, gastrointestinal (GI) conditions with unmet needs. Its pipeline includes Vurolenatide, Larazotide, NM-102, NM-003, NM-136 and NM-004. Vurolenatide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist that combines exenatide with an extended half-life technology for treatment of short bowel syndrome (SBS). Larazotide is an 8-amino acid peptide formulated into an orally administered capsule for treatment of celiac disease. NM-102 is a small molecule peptide, is being developed as a potential microbiome modulator and is undergoing an indication selection process. NM-003 is a long-acting GLP-2 receptor agonist, for prevention of acute graft versus host disease. NM-004 is a double-cleaved mesalamine with an immunomodulator for pediatric ulcerative colitis.

Closing Price
$1.32
Day's Change
-0.06 (-4.35%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.43
Day's Low
1.29
Volume
(Light)
Volume:
68,308

10-day average volume:
93,213
68,308
  • Prev Close
    1.38
  • Today's Open
    1.37
  • Day's Range
    1.29-1.43
  • Avg Vol (10-day)
    93.2K
  • Last (time)
    4:00p ET 03/20/23
  • Last (size)
    1
  • 52-Wk Range
    1.00 - 13.20
    LowHigh
  • (06/09/22 - 12/29/22)
    32.00%
  • 124.5%
  • Market Cap
    18.9M
  • Shares Outstanding
    14.3M
  • -3.20
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.4
  • 16.62
  • (% of float 02/28/23)
    3.13

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.